The study in patients receiving chemotherapy showed that Silapo was also effective when it was injected subcutaneously, with similar improvements in haemoglobin levels as those reported in the scientific literature for other epoetins.
Keemiaravi saavate patsientide uuring näitas, et Silapo oli efektiivne ka subkutaansel süstimisel, parandades hemoglobiinitaset sama efektiivselt kui teadusliku kirjanduse andmeil teised epoetiinid.